What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall involving specific batches of Clinere Carbamide Peroxide, an over-the-counter earwax removal aid distributed by Quest Products LLC. This action centers on two distinct distribution scenarios that have come to light during routine quality control and regulatory monitoring. The first scenario involves a package containing two bottles of Clinere Carbamide Peroxide, with each bottle holding 0.50 mL of the solution at a concentration of 6.5%. These smaller units are packaged together in a single retail-ready box. The second scenario involves individual retail packages containing one bottle of the same Clinere Carbamide Peroxide product, though the labeling indicates a volume of 0.50 fl. oz. (approximately 15 mL). While the volume description varies slightly between the bulk two-pack and the single-unit packaging, both contain the active ingredient carbamide peroxide intended for ear care.
To help you identify whether your product is part of this recall, it is essential to look closely at the National Drug Code (NDC) and the lot numbers printed on the packaging. The recalled items are distributed under NDC 68229-102-01. For the two-bottle packs, the affected lot number is 1504241, with an expiration date of March 2027. For the single-bottle packages, there are two specific lot numbers to watch for: 1504291 and 1504301, both of which also carry an expiration date of March 2027. The manufacturer listed on these products is Bell Pharmaceuticals, Inc., while distribution is handled by Quest Products LLC, located in Pleasant Prairie, Wisconsin. If you purchased this product recently, check the bottom or back of the box for these specific lot codes and NDC numbers, as the expiration date alone will not be sufficient to confirm whether your item is part of this recall.
This recall covers products that have been distributed nationwide across the United States, meaning they could be in pharmacies, grocery stores, or online retailers in any state. Although the FDA records indicate a specific focus on distribution patterns including Minnesota (MN), the nationwide scope means consumers from coast to coast should verify their inventory. The recall was initiated on June 25, 2026, following the identification of significant quality deviations. These products are typically found in the hearing care or ear hygiene sections of retail establishments. Because the distribution is broad and the lot numbers are specific, simply checking the brand name "Clinere" is not enough; you must cross-reference the lot number printed on your box against the three identified above to determine if your product needs to be returned.
The hazard, explained
When a recall is classified as "SubPotent," it means the product contains less of its active ingredient than it claims to have on the label. In this specific case involving Bell Pharmaceuticals’ Clinere, Carbamide Peroxide, the issue is twofold and particularly concerning. The FDA’s investigation revealed that the drug not only has a significantly reduced assay—meaning the actual concentration of carbamide peroxide is roughly 0.6% instead of the expected 6.5%—but also suffers from an abnormally low pH level. To understand why this combination is problematic, we need to look at how carbamide peroxide works and what happens when its chemical environment goes off track.
Carbamide peroxide is a common active ingredient in over-the-counter earwax removal products. When it comes into contact with the moisture in your ear canal, it typically breaks down into two main components: oxygen and urea. The oxygen creates tiny bubbles that help physically loosen and soften impacted earwax, making it easier to flush out. The urea acts as a mild keratolytic, meaning it helps break down the protein structure of the wax. For this chemical reaction to occur safely and effectively, the solution needs to be within a specific pH range that is gentle enough for the delicate skin of the ear canal but acidic enough to remain stable and active.
The primary danger here stems from the drastic drop in concentration. With an assay of only 0.6% compared to the labeled 6.5%, the product is roughly ten times weaker than advertised. Physically, this means that if you use the drops as directed, you are unlikely to get the intended therapeutic effect. You may find that your earwax remains impacted despite your efforts, leading to continued discomfort, muffled hearing, or even the temptation to use other tools or higher-dose products to compensate, which can increase the risk of injury.
However, the low pH level introduces a different type of physical hazard. The skin inside the ear canal is thin and sensitive. Solutions that are too acidic (low pH) can cause chemical irritation, leading to inflammation, redness, burning sensations, or dermatitis. While the subpotent nature means the drug won't work as intended, the incorrect acidity means it might actively irritate your ear tissue. This dual failure—ineffectiveness paired with potential irritation—is why the FDA has taken this action. It is not just that the product fails to help; it is that its chemical imbalance could cause unnecessary discomfort or damage to the sensitive structures of the outer ear.
It is important to distinguish this specific chemical hazard from more severe risks associated with contaminated drugs, such as bacterial growth. In this instance, the threat is primarily one of efficacy failure and local tissue irritation due to pH imbalance. The product does not appear to be contaminated with harmful microbes, but its altered chemical state makes it unsuitable for safe or effective use in the ear canal environment.
Who is most at risk
To understand who is truly vulnerable in this specific recall, we first need to look at what Clinere actually is and who typically reaches for it. This product is a carbamide peroxide solution, which is primarily used as an earwax removal aid or for the temporary relief of earache associated with wax buildup. Therefore, the individuals most directly exposed to this risk are those who have purchased these bottles from Quest Products LLC to treat their own hearing issues or to help family members manage earwax impaction. Because the distribution pattern is nationwide, any consumer in the United States who bought these specific items from pharmacies, online retailers, or medical supply stores could potentially be holding a subpotent batch in their home.
The core of the hazard here lies in the fact that the drug is "subpotent." The FDA’s testing revealed that the actual concentration of carbamide peroxide in these bottles was significantly lower than what is listed on the label—approximately 0.6% instead of the expected 6.5%. In plain terms, if you are following the instructions to soften earwax, this product is essentially doing very little of the work it promises. The risk here is not necessarily that the drug will harm your body directly through toxicity; rather, the danger stems from a false sense of security. You might believe you are treating a medical issue effectively, while the condition remains untreated or worsens because the medication lacks the necessary strength to break down the wax.
This dynamic creates a particular risk for older adults and individuals with naturally narrower ear canals or excessive cerumen production. As we age, earwax tends to become drier and harder, making it more difficult to remove naturally. When seniors attempt to use an ineffective product like this subpotent Clinere, they may continue to experience fullness, hearing loss, or discomfort. In their frustration, there is a heightened risk that they might resort to unsafe home remedies, such as using cotton swabs, bobby pins, or ear candles to force the wax out. These alternative methods are far more dangerous than taking an ineffective medication, as they can easily cause perforated eardrums, infections, or permanent hearing damage.
Additionally, parents of young children should be cautious. If you purchased this product to help a child who is complaining of ear fullness or mild pain, the subpotent nature of the drug means the underlying issue is not being addressed. Children may become irritable or sleep poorly due to continued discomfort. More importantly, if the wax remains impacted because the weak solution failed to work, it can lead to secondary issues like otitis externa (swimmer’s ear) or temporary conductive hearing loss, which can impact a child’s speech development and school performance if left unmanaged by a healthcare professional.
Ultimately, the people most at risk are not necessarily those suffering from acute chemical injury, but rather those delaying proper medical care. If you have been relying on this product to manage chronic earwax issues without success, you may be inadvertently allowing a simple, treatable condition to become a more complex medical problem that requires professional removal by an ENT specialist.
How to tell if you have the recalled item
Identifying whether your ear care products are part of this specific FDA recall requires a careful, methodical examination of your bottles. Because Bell Pharmaceuticals, Inc. distributed these items nationwide through Quest Products LLC, the packaging looks standard for over-the-counter earwax removal aids, which makes checking the fine print absolutely essential. You need to look at every bottle you have on hand that claims to be "Clinere" or contains Carbamide Peroxide. Do not rely solely on the front label, as the branding remains consistent across different production runs. Instead, turn your attention immediately to the back and sides of the packaging where the regulatory details are printed in smaller type.
The first thing you must verify is the National Drug Code (NDC). The recalled items specifically carry the NDC 68229-102-01. If your bottle has a different NDC, it is not part of this particular recall notice. Next, check the lot number and the expiration date printed on the label or the bottom of the bottle. There are two distinct groups of lots involved in this recall that you need to cross-reference against your product. The first group consists of Lot 1504241, which has an expiration date of March 2027. The second group includes Lots 1504291 and 1504301, both of which also expire in March 2027. If your bottle falls outside these specific lot numbers or if the expiration year is different, it is not included in this safety alert.
You should also pay close attention to the volume and concentration details on the label. The recall covers two specific package configurations. First, check if you have a twin-pack containing two bottles of Clinere Carbamide Peroxide 6.5%, where each bottle holds 0.50 mL (which is equivalent to 0.5 fl. oz. or 15 mL). Second, check for single packs containing one bottle of the same 6.5% concentration in a 0.50 fl. oz. (15 mL) size. It is critical to note that while the distribution pattern was nationwide, the specific classification and distribution details point to items distributed by Quest Products LLC, located in Pleasant Prairie, Wisconsin. If your bottle lacks the Quest Products LLC distributor information or does not match the exact NDC and lot combinations listed above, it is safe from this specific recall action.
To be absolutely certain, lay out all your earwax removal products and compare them side-by-side with the details provided here. Look for any discrepancies in the lot numbers ending in 241, 291, or 301. If you find a match for the NDC 68229-102-01 and one of those specific lots, stop using the product immediately. The discrepancy lies not in the visual appearance of the bottle, which looks normal, but in the chemical composition inside, which is subpotent due to low pH and significantly reduced assay levels. Therefore, physical inspection alone cannot confirm safety; only the printed lot and NDC data can tell you if your item is affected.
What to do — step by step
If you have purchased Clinere Carbamide Peroxide from Bell Pharmaceuticals, Inc., the most important thing to remember right now is that the official remedy or specific return instructions for this recall have not been stated in the FDA’s public announcement. While it might feel frustrating to lack a direct link or a toll-free number in the press release, you are still in control of your safety by following these logical, protective steps. Because this is a Class II recall involving a subpotent drug with significantly reduced assay levels (approximately 0.6% instead of the expected ~6-7%), the primary goal is to ensure that no one continues to use a product that may not work as intended.
- Stop using the product immediately. Even if you have not experienced any adverse effects, do not continue to use these bottles for earwax removal or any other purpose. The "subpotent" nature of this drug means it is essentially ineffective. Using it gives you a false sense of treatment while potentially delaying proper medical care for ear issues. Think of it like trying to put out a small fire with an empty water bottle; the effort might feel real, but the result will not be achieved.
- Identify your specific bottles. Check your storage area for the two distinct distribution patterns mentioned in the recall notice. Look for packages containing two 0.50 mL (0.5 fl. oz./15 mL) bottles of Clinere Carbamide Peroxide, 6.5%, with Lot number 1504241 expiring in March 2027. Alternatively, look for a single bottle distributed by Quest Products LLC in Pleasant Prairie, WI (NDC 68229-102-01) with Lot numbers 1504291 or 1504301, also expiring in March 2027. If you do not have the lot numbers handy, check your receipt or credit card statement to see if you bought it from a retailer that may have been notified.
- Contact the distributor for guidance. Since Bell Pharmaceuticals distributed this product through Quest Products LLC, your best course of action is to reach out to them directly. Visit the Quest Products website or call their customer service line. Explain that you possess a recalled lot of Clinere Carbamide Peroxide. Ask them specifically if they are processing refunds, offering replacements, or providing prepaid shipping labels for returns. They are the entity listed on the bottle and are likely handling the logistics of this Class II recall.
- Dispose of the product safely if no return option is available. If you cannot contact the distributor or if they advise that returns are closed, do not pour the chemical down your sink or toilet. Earwax removal solutions can contain irritants that may harm plumbing or local water systems. Instead, mix the contents with an unpalatable substance like cat litter, coffee grounds, or dirt in a sealed plastic bag to prevent accidental ingestion by children or pets, and place it in your household trash. This ensures the subpotent drug leaves your home safely without causing further confusion or harm.
- Monitor for health concerns. Because the drug is subpotent, the primary risk is treatment failure rather than toxicity. However, if you used these bottles recently and are still experiencing ear pain, fullness, or hearing loss, consult your healthcare provider. Do not assume the problem has resolved itself simply because you used the product; it likely did not work due to the low assay levels. Your doctor can recommend effective, properly potent alternatives.
By taking these steps, you are protecting yourself from ineffective treatment and helping maintain the integrity of the drug supply chain. Always keep your receipts for recalled items, as they serve as proof of purchase if a refund process is eventually opened by the company.
Your refund, repair, or replacement options
When you receive news that a medication has been recalled, the immediate question is often, "What do I do now?" and "How am I made whole?" In this specific instance involving Bell Pharmaceuticals, Inc. and their product Clinere Carbamide Peroxide, it is important to approach the remedy with clarity and calm. The official FDA recall documentation for this Class II recall does not explicitly list a standardized consumer remedy, such as a direct refund portal, a prepaid return shipping label, or a guaranteed replacement kit. This absence of a pre-defined consumer-facing remedy in the public record does not mean you are without recourse; rather, it means you must take a slightly more proactive step to resolve your situation.
Because the recall is driven by significant quality control failures—specifically, the product having a low pH and a drastically reduced assay of approximately 0.6% compared to the expected 6.5%—the manufacturer has a legal and ethical obligation to address the harm caused to consumers. Even though the official notice does not spell out the exact terms, you should contact the distributor, Quest Products LLC, located in Pleasant Prairie, Wisconsin, directly. They are the entity responsible for distribution and are typically the first point of contact for logistical issues regarding recalled goods. When you reach out, explain clearly that you possess a lot from the affected batches (Lot numbers 1504241, 1504291,—or